Literature DB >> 17327311

Glycemic and risk factor control in type 1 diabetes: results from 13,612 patients in a national diabetes register.

Katarina Eeg-Olofsson1, Jan Cederholm, Peter M Nilsson, Soffia Gudbjörnsdóttir, Björn Eliasson.   

Abstract

OBJECTIVE: This study was designed to investigate the clinical characteristics of a large type 1 diabetic population and to evaluate the degree of fulfillment of recently updated treatment goals. RESEARCH DESIGN AND METHODS: The Swedish National Diabetes Register was initiated in 1996 as a tool for quality assurance in diabetes care. A1C levels, treatment, and risk factors were analyzed in two cross-sectional samples of 9,424 patients in 1997 and 13,612 patients in 2004 and in a smaller longitudinal sample from 1997 to 2004.
RESULTS: Mean A1C decreased from 8.2 +/- 1.3% in 1997 to 8.0 +/- 1.2% in 2004 (P < 0.001). The proportion of patients reaching A1C <7.0% increased from 17.4 to 21.2% in 2004. A slow but significant improvement in blood pressure levels was seen, but only 61.3% reached the blood pressure goal of <130/80 mmHg in 2004. Lipid control improved, and the use of lipid-lowering drugs increased. Among patients treated with lipid-lowering agents, 38% reached the goal of total cholesterol <4.5 mmol/l, and 48% reached the goal of LDL cholesterol <2.5 mmol/l. Successful long-term glycemic and blood pressure control were both independently predicted by low BMI and the absence of microalbuminuria in 1997.
CONCLUSIONS: In this large cohort of type 1 diabetic patients, there was a slow improvement in glycemic and risk factor control from 1997 to 2004, although the gap between the clinical results and current Swedish and American treatment goals is still unsatisfactory. It is crucial that additional measures be taken to improve risk factor control in type 1 diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17327311     DOI: 10.2337/dc06-1406

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  23 in total

1.  Long-term detrimental consequences of the onset of type 1 diabetes on annual earnings--evidence from annual registry data in 1990-2005.

Authors:  K Steen Carlsson; M Landin-Olsson; L Nyström; H J Arnqvist; J Bolinder; J Ostman; S Gudbjörnsdóttir
Journal:  Diabetologia       Date:  2009-12-18       Impact factor: 10.122

Review 2.  Target blood pressure in diabetes patients with hypertension--what is the accumulated evidence in 2011?

Authors:  Peter M Nilsson
Journal:  J Zhejiang Univ Sci B       Date:  2011-08       Impact factor: 3.066

3.  Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR).

Authors:  Katarina Eeg-Olofsson; Jan Cederholm; Peter M Nilsson; Björn Zethelius; Ann-Marie Svensson; Soffia Gudbjörnsdóttir; Björn Eliasson
Journal:  Diabetes Care       Date:  2010-04-27       Impact factor: 19.112

Review 4.  Autologous umbilical cord blood infusion for type 1 diabetes.

Authors:  Michael J Haller; Hilla-Lee Viener; Clive Wasserfall; Todd Brusko; Mark A Atkinson; Desmond A Schatz
Journal:  Exp Hematol       Date:  2008-03-20       Impact factor: 3.084

5.  In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes.

Authors:  Francesco Micheletto; Chiara Dalla Man; Orville Kolterman; Elaine Chiquette; Kathrin Herrmann; Jörg Schirra; Boris Kovatchev; Claudio Cobelli
Journal:  Diabetes Technol Ther       Date:  2013-07-18       Impact factor: 6.118

Review 6.  Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Authors:  L Peyrin-Biroulet; W Sandborn; B E Sands; W Reinisch; W Bemelman; R V Bryant; G D'Haens; I Dotan; M Dubinsky; B Feagan; G Fiorino; R Gearry; S Krishnareddy; P L Lakatos; E V Loftus; P Marteau; P Munkholm; T B Murdoch; I Ordás; R Panaccione; R H Riddell; J Ruel; D T Rubin; M Samaan; C A Siegel; M S Silverberg; J Stoker; S Schreiber; S Travis; G Van Assche; S Danese; J Panes; G Bouguen; S O'Donnell; B Pariente; S Winer; S Hanauer; J-F Colombel
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

7.  Analysis of a comprehensive diabetic retinopathy screening model for rural and urban diabetics in developing countries.

Authors:  Padmaja Kumari Rani; Rajiv Raman; Vikranth Sharma; Sachin Vasant Mahuli; Arokiasamy Tarigopala; R R Sudhir; Govindasamy Kumaramanickavel; Tarun Sharma
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

Review 8.  Achieving HbA1c targets in clinical trials and in the real world: a systematic review and meta-analysis.

Authors:  Edoardo Mannucci; Matteo Monami; Ilaria Dicembrini; Attilio Piselli; Massimo Porta
Journal:  J Endocrinol Invest       Date:  2014-04-04       Impact factor: 4.256

9.  Improved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysis.

Authors:  Klemen Dovc; Sasa Starc Telic; Lara Lusa; Nina Bratanic; Mojca Zerjav-Tansek; Primoz Kotnik; Magdalena Avbelj Stefanija; Tadej Battelino; Natasa Bratina
Journal:  Diabetes Technol Ther       Date:  2013-10-16       Impact factor: 6.118

10.  Diabetes, hypertension, and outcome studies: overview 2010.

Authors:  Peter M Nilsson; Jan Cederholm
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.